OncoNet Rhein-Main and Molecular Health cooperate to offer optimal therapy decisions for cancer patients

RZ_0147-0001-107_Website_Anwender_Cases_OncoNet_Rhein-Main_Logo-OncoNet_21-12-02
The OncoNet Rhein-Main is a network of clinics, molecular pathology laboratories, practices and medical centers that aims to provide effective and targeted care to all cancer patients in the Rhein-Main area. Working together, partners in the network support clinical studies to integrate innovative therapy approaches into daily clinical practice.

“We are very pleased about our collaboration with Molecular Health. We are united by the common goal of providing optimal treatment to people with cancer. With MH Guide, we have a digital tool for interdisciplinary case discussions in our tumor board. The interactive platform lets us correctly identify the steadily growing number of known genetic alterations in tumors to make the best possible treatment decisions.”

Prof. Dr. Christian Jackisch,
OncoNet Rhein-Main board member; chief physician at Sana Klinikum Offenbach

Challenge
The OncoNet Rhein-Main network strives to offer cancer patients access to novel therapies via ongoing clinical studies. Matching patients and studies is challenging due to the increasing complexity and continually evolving landscape of molecular data in oncology.

Solution
As a regionally networked partner of the Rhein-Main area, Molecular Health supports therapy decisions by clinicians and pathologists with the structured processing and interpretation of next-generations sequencing (NGS) tumor profiles. Partners of OncoNet Rhein- Main receive onsite training to incorporate MH Guide into their translation of molecular data into practicable treatment decisions.

Patient benefit
The coverage in MH Guide of latest research findings, treatment recommendations, and ongoing clinical trials offer healthcare providers of the OncoNet Rhein-Main a rapid and accurate overview of approved and investigational therapy options. With detailed information about detected variants, all stakeholders can engage in multidisciplinary discussions to identify the best path for a patient based on a shared understanding of NGS data and, thus, offer patients individualized care.

More case studies

Genopath Logo

GENOPATH GbR

With head offices in Bonn, Germany, GENOPATH GbR is an association of 16 pathology institutes. The group formed to supply all member laboratories with top-quality and cutting-edge molecular diagnostic services that complement existing histological and cytological methods, making the comprehensive care available to every cancer patient.

Read more

Charité Institute of Pathology

The Institute of Pathology at the Charité Berlin is a key player in the care of cancer patients of the country’s capital and surrounding area. Their broad spectrum of analytical methods covers histological, cytological, and molecular diagnostics to deliver the reliable and timely identification of therapeutic options.

Read more

Gen Era Diagnostics

Gen Era Diagnostics is a leading provider of molecular diagnostics products and services in Turkey. The company has empowered scientists, clinicians, and laboratories in the investigation of diseases and the treatment of patients since 2013 with a comprehensive offering of cutting-edge research and diagnostic technologies.

Read more

Contact form

Many Thanks!

Your request was successfully sent.